Arcus Biosciences, Inc. — Director's Dealing 2019

Jun 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2019-06-03

Reporting Person: ROSEN TERRY J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-03	Common Stock	P	15770	$8.1642	Acquired	2975631	Indirect
2019-06-04	Common Stock	P	25770	$7.7542	Acquired	3001401	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	500000	Indirect
Common Stock	500000	Indirect
Common Stock	189393	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.42 to $8.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F3: Shares previously held by The Rosen Family Trust.